» Articles » PMID: 25374808

Why Do Young People with Chronic Kidney Disease Die Early?

Overview
Journal World J Nephrol
Specialty Nephrology
Date 2014 Nov 7
PMID 25374808
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular disease poses the greatest risk of premature death seen among patients with chronic kidney disease (CKD). Up to 50% of mortality risk in the dialysis population is attributable to cardiovascular disease and the largest relative excess mortality is observed in younger patients. In early CKD, occlusive thrombotic coronary disease is common, but those who survive to reach end-stage renal failure requiring dialysis are more prone to sudden death attributable mostly to sudden arrhythmic events and heart failure related to left ventricular hypertrophy, coronary vascular calcification and electrolyte disturbances. In this review, we discuss the basis of the interaction of traditional risk factors for cardiovascular disease with various pathological processes such as endothelial dysfunction, oxidative stress, low grade chronic inflammation, neurohormonal changes and vascular calcification and stiffness which account for the structural and functional cardiac changes that predispose to excess morbidity and mortality in young people with CKD.

Citing Articles

Differential Myocardial Responses in Male and Female Rats with Uremic Cardiomyopathy.

Bodi B, Vago R, Nagy L, Raduly A, Gulyas A, Kupecz K Int J Mol Sci. 2025; 26(5).

PMID: 40076880 PMC: 11900185. DOI: 10.3390/ijms26052259.


Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4.

Amador-Martinez I, Aparicio-Trejo O, Bernabe-Yepes B, Aranda-Rivera A, Cruz-Gregorio A, Sanchez-Lozada L Int J Mol Sci. 2023; 24(21).

PMID: 37958859 PMC: 10650149. DOI: 10.3390/ijms242115875.


Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies.

Vyletelova V, Novakova M, Paskova L Pharmaceuticals (Basel). 2022; 15(10).

PMID: 36297390 PMC: 9611871. DOI: 10.3390/ph15101278.


Renal and Urological Disorders Associated With Inflammatory Bowel Disease.

Kumar S, Pollok R, Goldsmith D Inflamm Bowel Dis. 2022; 29(8):1306-1316.

PMID: 35942657 PMC: 10393213. DOI: 10.1093/ibd/izac140.


Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs.

Kim H, Kim S, Song S Korean J Intern Med. 2022; 37(3):502-519.

PMID: 35368179 PMC: 9082447. DOI: 10.3904/kjim.2021.515.


References
1.
Ronco C, Haapio M, House A, Anavekar N, Bellomo R . Cardiorenal syndrome. J Am Coll Cardiol. 2008; 52(19):1527-39. DOI: 10.1016/j.jacc.2008.07.051. View

2.
Tripepi G, Mattace Raso F, Sijbrands E, Seck M, Maas R, Boger R . Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol. 2011; 6(7):1714-21. DOI: 10.2215/CJN.11291210. View

3.
Amirmansour C, Vallance P, Bogle R . Tyrosine nitration in blood vessels occurs with increasing nitric oxide concentration. Br J Pharmacol. 1999; 127(3):788-94. PMC: 1566060. DOI: 10.1038/sj.bjp.0702590. View

4.
Bradbury B, Fissell R, Albert J, Anthony M, Critchlow C, Pisoni R . Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007; 2(1):89-99. DOI: 10.2215/CJN.01170905. View

5.
Stuhlinger M, Oka R, Graf E, Schmolzer I, Upson B, Kapoor O . Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation. 2003; 108(8):933-8. DOI: 10.1161/01.CIR.0000085067.55901.89. View